Literature DB >> 2449123

9-(trans-2',trans-3'-Dihydroxycyclopent-4'-enyl)-adenine and -3-deazaadenine: analogs of neplanocin A which retain potent antiviral activity but exhibit reduced cytotoxicity.

M Hasobe1, J G McKee, D R Borcherding, R T Borchardt.   

Abstract

Two synthetic analogs of neplanocin A, which were shown in a separate study to be inhibitors of S-adenosylhomocysteine hydrolase and devoid of substrate activity with adenosine kinase, were found in this study to inhibit vaccinia virus replication in murine L929 cells but to have reduced cytotoxicity compared with that of the parent compound. These results confirm that S-adenosylhomocysteine hydrolase is the molecular target which mediates the antiviral effects of neplanocin A and that transformation by cellular adenosine kinase mediates its cytotoxic properties.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2449123      PMCID: PMC175052          DOI: 10.1128/AAC.31.11.1849

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  11 in total

1.  Capping of eucaryotic mRNAs.

Authors:  A J Shatkin
Journal:  Cell       Date:  1976-12       Impact factor: 41.582

2.  Antiviral potency of adenosine analogues: correlation with inhibition of S-adenosylhomocysteine hydrolase.

Authors:  E De Clercq; M Cools
Journal:  Biochem Biophys Res Commun       Date:  1985-05-31       Impact factor: 3.575

Review 3.  Pharmacological and biochemical aspects of S-adenosylhomocysteine and S-adenosylhomocysteine hydrolase.

Authors:  P M Ueland
Journal:  Pharmacol Rev       Date:  1982-09       Impact factor: 25.468

4.  Inhibition of intractable nucleases with ribonucleoside--vanadyl complexes: isolation of messenger ribonucleic acid from resting lymphocytes.

Authors:  S L Berger; C S Birkenmeier
Journal:  Biochemistry       Date:  1979-11-13       Impact factor: 3.162

5.  Neplanocin A. A potent inhibitor of S-adenosylhomocysteine hydrolase and of vaccinia virus multiplication in mouse L929 cells.

Authors:  R T Borchardt; B T Keller; U Patel-Thombre
Journal:  J Biol Chem       Date:  1984-04-10       Impact factor: 5.157

6.  Studies on neplanocin A, new antitumor antibiotic. I. Producing organism, isolation and characterization.

Authors:  S Yaginuma; N Muto; M Tsujino; Y Sudate; M Hayashi; M Otani
Journal:  J Antibiot (Tokyo)       Date:  1981-04       Impact factor: 2.649

7.  Purification and characterization of some metabolic effects of S-neplanocylmethionine.

Authors:  B T Keller; R S Clark; A E Pegg; R T Borchardt
Journal:  Mol Pharmacol       Date:  1985-10       Impact factor: 4.436

8.  Neplanocin A. A cyclopentenyl analog of adenosine with specificity for inhibiting RNA methylation.

Authors:  R I Glazer; M C Knode
Journal:  J Biol Chem       Date:  1984-11-10       Impact factor: 5.157

9.  Antiviral and antimetabolic activities of neplanocins.

Authors:  E De Clercq
Journal:  Antimicrob Agents Chemother       Date:  1985-07       Impact factor: 5.191

10.  Adenosine dialdehyde: a potent inhibitor of vaccinia virus multiplication in mouse L929 cells.

Authors:  B T Keller; R T Borchardt
Journal:  Mol Pharmacol       Date:  1987-05       Impact factor: 4.436

View more
  15 in total

1.  Broad-spectrum antiviral activities of neplanocin A, 3-deazaneplanocin A, and their 5'-nor derivatives.

Authors:  E De Clercq; M Cools; J Balzarini; V E Marquez; D R Borcherding; R T Borchardt; J C Drach; S Kitaoka; T Konno
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

2.  Phosphoanalogues of amino acids involved in methionine metabolism as a new source of antiviral compounds.

Authors:  R M Khomutov; A I Shchipanova; E N Khurs
Journal:  Dokl Biochem Biophys       Date:  2009 Mar-Apr       Impact factor: 0.788

3.  Carbocyclic thymidine analogues for use as potential therapeutic agents.

Authors:  Katherine L Seley-Radtke; Naresh K Sunkara
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2009-05       Impact factor: 1.381

Review 4.  Vaccinia virus inhibitors as a paradigm for the chemotherapy of poxvirus infections.

Authors:  E De Clercq
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

5.  Carbocyclic pyrimidine nucleosides as inhibitors of S-adenosylhomocysteine hydrolase.

Authors:  Sylvester L Mosley; Brian A Bakke; Joshua M Sadler; Naresh K Sunkara; Kathleen M Dorgan; Zhaohui Sunny Zhou; Katherine L Seley-Radtke
Journal:  Bioorg Med Chem       Date:  2006-08-10       Impact factor: 3.641

6.  Synthetic strategies toward carbocyclic purine-pyrimidine hybrid nucleosides.

Authors:  Joshua M Sadler; Sylvester L Mosley; Kathleen M Dorgan; Zhaohui Sunny Zhou; Katherine L Seley-Radtke
Journal:  Bioorg Med Chem       Date:  2009-06-23       Impact factor: 3.641

7.  A molecular model for the active site of S-adenosyl-L-homocysteine hydrolase.

Authors:  J C Yeh; R T Borchardt; A Vedani
Journal:  J Comput Aided Mol Des       Date:  1991-06       Impact factor: 3.686

8.  Relationship between intracellular concentration of S-adenosylhomocysteine and inhibition of vaccinia virus replication and inhibition of murine L-929 cell growth.

Authors:  M Hasobe; J G McKee; R T Borchardt
Journal:  Antimicrob Agents Chemother       Date:  1989-06       Impact factor: 5.191

9.  Historical perspectives in the development of antiviral agents against poxviruses.

Authors:  Erik De Clercq
Journal:  Viruses       Date:  2010-06-14       Impact factor: 5.818

Review 10.  Flexibility-Not just for yoga anymore!

Authors:  Katherine Seley-Radtke
Journal:  Antivir Chem Chemother       Date:  2018 Jan-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.